SeQuent Scientific’s subsidiary Alivira Animal Health (Alivira) has completed the acquisition of majority stake in Karizoo Group, Spain. The transaction has now achieved closure and Karizoo Group (Vila Vina Particpacions) will be integrated and consolidated with the company effective July 01, 2016.
Earlier in May, Alivira had signed a definitive agreement to acquire majority stake in Karizoo Group, Spain, one of the leading animal health groups in Spain and European markets. The agreement was to acquire 60% stake in the family held Vila Vina Particpacions (VVP) which owns Karizoo Spain, Phytosolutions Spain, Covivet Spain and Karizoo Mexico.
Sequent Scientific is an integrated pharmaceutical company with a global footprint headquartered in Bangalore, India which has presence in different pharmaceutical verticals including APIs, Animal Health, Analytical Services, CRAMS and specialty chemicals. Sequent is the world's largest producer of Anthelmintics and by far the strongest player in the Veterinary API business.
